Search results
FTC targets 300 Big Pharma 'junk patents,' sends warning letters to top drugmakers
BenefitsPRO· 11 hours agoThe Federal Trade Commission is stepping up its crackdown on so-called "junk patents," which it...
Nuvectis Pharma exec buys shares worth over $7,000 By Investing.com
Investing.com· 3 days agoIn a recent transaction on May 10, 2024, Shay Shemesh, the Chief Development & Operations Officer at...
Earnings call: Biora Therapeutics reports progress on NaviCap and BioJet platforms By Investing.com
Investing.com· 2 hours agoBiora Therapeutics (NASDAQ:BIOR) has announced significant advancements in its NaviCap and BioJet...
Watch: Aaron Rodgers Tells Tucker Carlson How the NFL Forced Players to Get Vaccinated – ‘Follow the...
IJR· 13 hours agoAaron Rodgers dished about vaccines, pharmaceutical companies, government corruption and more during...
Pelosi Schooled by Banjo Player at University Debate
IJR· 2 days agoNancy Pelosi might have won the battle, but the war is a different story. On a trip to England in April, the former House speaker kept up her crusade...
April CPI: Consumer prices rose 0.3%, slower than analysts expected
United Press International via Yahoo Finance· 11 hours agoThe consumer price index increased to a seasonally adjusted 0.3% in April compared to the month...
OCT Europe: Unless everyone is benefiting, what is the point?
Pharmaceutical Technology via Yahoo Finance· 14 hours agoPatient-centricity has been a buzzword in the clinical trial industry for the past few years with...
US consumer inflation resumes downward trend as domestic demand cools
Reuters via AOL· 13 hours agoU.S. consumer prices increased less than expected in April, suggesting that inflation resumed its...
A pill could solve the Zepbound and Wegovy shortage, Eli Lilly executive says
Quartz· 16 hours agoIt may take a weight loss pill for Eli Lilly to finally meet demand for its popular anti-obesity...
Mayne Pharma Group Limited's (ASX:MYX) largest shareholders are individual investors with 38%...
Simply Wall St. via Yahoo Finance· 3 days agoInstitutional investors commonly compare their own returns to the returns of a commonly followed...